<--> SHORE-C: Sussex Health Outcomes Research and Education in Cancer


Jacobs IJ, Menon U, Ryan A, Gentry-Maharaj A, Burnell M, Kalsi JK, Amso NN, ApostolidouS, Benjamin E, Cruickshank D, Crump DN, Davies SK, Dawnay A, Dobbs S, Fletcher G, Ford J, Godfrey K, Gunu R, Habib M, Hallett R, Herod J, Jenkins H, Karpinskyj C, Leeson S, Lewis SJ, Liston WR, Lopes A, Mould T, Murdoch J, Oram D, Rabideau DJ, Reynolds K, Scott I, Seif MW, Sharma A, Singh N, Taylor J, Warburton F, Widschwendter M, Williamson K, Woolas R, Fallowfield L, McGuire AJ, Campbell S, Parmar M, Skates SJ. Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. The Lancet 387(10022): p945–956, 5 March 2016 . Open Access article first published online 17th December 2015 ahead of print.

von Moos R , Body JJ , Egerdie B , Stopeck A , Brown J , Fallowfield L , Patrick DL , Cleeland C , Damyanov D , Palazzo FS , Marx G , Zhou Y , Braun A , Balakumaran A , Qian Y. Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 2016, 24(3):1327-1337, First published online 2 September 2015.

Kneebone II, Fife-Schaw C, Lincoln NB, Harder H. A study of the validity and the reliability of the Geriatric Anxiety Inventory in screening for anxiety after stroke in older inpatients. Clinical Rehabilitation 2015, 1–9.

Francis A, Thomas J, Fallowfield L, Wallis M, Bartlett JMS, Brookes C, Roberts T, Pirrie S, Gaunt C, Young J, Billingham L, Dodwell D, Hanby A, Pinder SE, Evans A, Reed M, Jenkins V, Matthews L, Wilcox M, Fairbrother P, Bowden S, Rea D.   Addressing overtreatment of screen detected DCIS; the LORIS trial.  European Journal of Cancer, 2015(51)16, 2296–2303

Jenkins V, Fallowfield L, Langridge C, Barrett J, Ryan A, Jacobs I, Kilkerr J, Menon U, Farewell V.   Psychosocial Factors Associated With Withdrawal From the United Kingdom Collaborative Trial of Ovarian Cancer Screening following 1 Episode of Repeat Screening.  International Journal of Gynecological Cancer, 2015 (8):1519-25

Pagani O, Fallowfield L, Bergsten Nordstrom E, Knox S. Metastatic Breast Cancer: Focus for Advocacy. EUROPA DONNA Breast Cancer Advocacy Leader Conference September 2014 brochure.

Morris C, Janssens A, Shilling V, Allard A, Fellowes A, Tomlinson R, Williams J, Thompson Coon J, Rogers M, Beresford B, Green C, Jenkinson C, Tennant A, Logan S. Meaningful health outcomes for paediatric neurodisability: Stakeholder prioritisation and appropriateness of patient reported outcome measures. Health and QoL Outcomes 2015, 13:87

Menon U, Kalsi R, Gentry-Haharaj A, Dawnay A, Habib M, Apostolidou S, Singh N, Benjamin E, Burnell M, Davies S, Sharma A, Gunu R, Godfrey K, Lopes A, Oram D, Herod J, Williamson K, Seif MW, Jenkins H, Mould T, Woolas R, Murdoch JB, Dobbs S, Amso NN, Leeson S, Cruickshank D, Scott I, Fallowfield L, Widschwendter M, Reynolds K, McGuire A, Campbell S, Parmar M, Skates SJ, Jacobs I. Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening. Journal of Clinical Oncology. 2015 May 11. pii: JCO.2014.59.4945. Article first published online 11 May 2015.

 L Menlove, E Crayton,I Kneebone, R Allen-Crooks, E Otto, H Harder.  Predictors of Anxiety after Stroke: A Systematic Review of Observational Studies. Article first published online 25th March 2015.

Jenkins V, Fallowfield L.  For the Benefit of Others: Reasons Why Women with Breast Cancer Participate in RCTs.  Breast Care 2015:10:88-93. Article first published online 17 February 2015. doi:10.1159/000376563

Harder H, Langridge C, Solis-Trapala I, Zammit C, Grant M, Rees D, Burkinshaw L, Jenkins V.  Post-operative exercises after breast cancer surgery: Results of a RCT evaluating standard care versus standard care plus additional yoga exercise.  European Journal of Integrative Medicine 2015, Article first published online 9 March 2015.

Fallowfield L, Osborne S, Langridge C, Monson K, Kilkerr J, Jenkins V.  Implications of subcutaneous or intravenous delivery of trastuzumab; further insight from patient interviews in the PrefHer study.  The Breast, Article first published online 23 January 2015.

Shilling V, Bailey S, Logan S, Morris C. Peer support for parents of disabled children part 2: how organizational and process factors influenced shared experience in a one-to-one service, a qualitative study. Child: Care Health and Development. Article first published online 2 Jan 2015 doi: 10.1111/cch.12222


^ Top

Shilling V, Bailey S, Logan S, Morris C. Child: Care Health and Development. Article first published online: 17 Dec 2014. doi: 10.1111/cch.12223.

Francis A, Fallowfield L, Rea D.  The LORIS Trial: Addressing Overtreatment of Ductal Carcinoma In Situ Clinical Oncology 2015, 27(1):6-8 doi: 10.1016/j.clon.2014.09.015. E-published in 2014

Fallowfield L, Jenkins V. Psychosocial/Survivorship Issues in Breast Cancer: Are We Doing Better? JNCI Journal of the National Cancer Institute 2014, 107(11), doi:10.1093/jnci/dju335

Palmieri C, Cleator S, Kilburn LS, Kim SB, Ahn SH, Beresford M, Gong G, Fallowfield L, Cheang M, Morden J, Page K, Guttery DS, Rghebi B, Primrose L, Shaw JA, Thompson AM, Bliss JM, Coombes RC. NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancer. Breast Cancer Research and Treatment 148(3):581-590. doi:10.1007/s10549-014-3183-4

Fallowfield L, Guarneri V, Ozturk MA, May S, Jenkins V. Blurring of boundaries in the doctor-patient relationship. The Lancet Oncology, 15(13);1423-1424 doi:10.1016/S1470-2045(14)71122-2

Cherny NI, de Vries EGE, Emanuel L, Fallowfield L, Francis PA, Gabison A, Piccart MJ, Sidransky D, Soussan-Gutman L, Tziraki C. Words Matter: Distinguishing “Personalized Medicine” and “Biologically Personalized Therapeutics” Journal of the National Cancer Institute 106(12): dju321 doi:10.1093/jnci/dju321

Hopkins TG, Stavraka C, Gabra H, Fallowfield L, Hood C, Blagden S. Sexual activity and functioning in ovarian cancer survivors: an internet-based evaluation. Climacteric 2015 Feb;18(1):94-8 epublished 2014

Cardoso F, Costa A, Norton L, Senkus E, Aapro M, Andre F, Barrios CH, Bergh J, Biganzoli L, Blackwell KL, Cardoso MJ, Cufer T, El Saghir N, Fallowfield L, Fenech D, Francis P, Gelmon K, Giordano SH, Gligorov J, Goldhirsch A, Harbeck N, Houssami N, Hudis C, Kaufman B, Krop I, Kyriakides S, Lin UN, Mayer M, Merjaver SD, Nordstrom EB, Pagani O, Partridge A, Penault-Llorca F, Piccart MJ, Rugo H, Sledge G, Thomssen C, van't Veer L, Vorobiof D, Vrieling C, West N, Xu B, Winer E. ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2). Annals of Oncology, 25(10);1871-1888 published simultaneously in The Breast, 23(5);489-502

Gligorov J, Müller V, Curigliano G, Knoop A, Verma S, Jenkins V, Scotto N, Osborne S, Fallowfield L on behalf of the PrefHer Study Group. Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study. Annals of Oncology 25:1979-1987

Fallowfield L, Matthews L, Francis A, Jenkins V, Rea D. Low grade Ductal Carcinoma in situ (DCIS): How best to describe it?. The Breast, 23(5); 693-696

Stoner KL, Harder H, Fallowfield LJ, Jenkins VA. Intravenous versus Subcutaneous Drug Administration. Which do Patients Prefer? A Systematic Review. The Patient - Patient-Centred Outcomes Research 2015, 8(2):145-153. E-Published 12 July 2014

El Saghir NS, Keating NL, Carlson RW, Khoury KE, Fallowfield L. Tumor boards: optimizing the structure and improving efficiency of multidisciplinary management of patients with cancer worldwide. American Society of Clinical Oncology Education Book 2014;34:e461-6

Treasure T, Brew-Graves C, Fallowfield L, Farewell V, Golesworthy T, Leonard P, Monson K, Russell C. The need to determine whether lung metastasectomy improves survival in advanced colorectal cancer.  British Medical Journal Letters BMJ 2014;348:g4085

Barrett J, Jenkins V, Farewell , Menon U, Jacobs I, Kilkerr J, Ryan A, Langridge C, Fallowfield L for and on behalf of UKCTOCS trialists. Psychological morbidity associated with ovarian cancer screening: results from more than 23 000 women in the randomised trial of ovarian cancer screening (UKCTOCS)BJOG An International Journal of Obstetrics & Gynaecology. 2014, 121(9):1071–1079

Treasure T, Monson K, Fiorentino F, Russell C. The CEA Second-Look Trial: a randomised controlled trial of carcinoembryonic antigen prompted reoperation for recurrent colorectal cancer.  British Medical Journal Open 2014:e004385. doi:10.1136/bmjopen-2013-004385

Treasure T, Monson K, Fiorentino F, Russell C. Operating to remove recurrent colorectal cancer: have we got it right?  British Medical Journal Open 2014:348:g2085. doi:10.1136/bmj.g2085

Fallowfield L, Langridge C, Jenkins V. Communication skills training for breast cancer teams talking about trials.  The Breast 23(2): 193-197, 2014 http://dx.doi.org/10.1016/j.breast.2013.11.009


^ Top

von Moos R, Body JJ, Egerdie B, Stopeck A, Brown JE, Damyanov D, Fallowfield LJ, Marx G, Cleeland CS, Patrick DL, Palazzo FG, Qian Y, Braun A, Chung K. Pain and health-related QoL in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid. Support Care Cancer 21(12): 3497-507, 2013. doi: 10.1007/s00520-013-1932-2

Pivot X, Gligorov J, Müller V, Barrett-Lee P, Verma S, Knoop A, Curigliano G, Semiglazov V, López-Vivanco G, Jenkins V, Scotto N, Osborne S, Fallowfield LJ for the PrefHer Study Group Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study. The Lancet Oncology 14(10): 962-70, 2013 doi:10.1016/S1470-2045(13)70383-8

Migliore M, Lees B, Treasure T, Fallowfield LJ Randomized controlled trial of pulmonary metastasectomy in colorectal cancer: PulMiCC International is open in Italy.  Oncologist (18)5: 637, 2013 doi:10.1634/theoncologist.2012-0476

Harder H, Ballinger R, Langridge C, Ring A, Fallowfield LJ Adjuvant chemotherapy in elderly women with breast cancer: patients' perspectives on information giving and decision making. Psycho-Oncology (22)12: 2729-2735, 2013, doi:10.1002/pon.3338

Jenkins V*, Catt S, Banerjee S, Gourley C, Montes A, Solis-Trapala I, Monson K and Fallowfield LJ Patients’ and oncologists’ views on the treatment and care of advanced ovarian cancer in the UK: results from the ADVOCATE study. British Journal of Cancer 108(11): 2264-71, 2013 doi:10.1038/bjc.2013.223

Lin NU, et al., International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO) eMBC Task Force: Surveillance, staging, and evaluation of patients with early-stage and metastatic breast cancer. The Breast 22(3): 203-10, 2013, http://dx.doi.org/10.1016/j.breast.2013.03.006

Jenkins V, Farewell V, Farewell D, Darmanin J, Wagstaff J, Langridge C, Fallowfield LJ. Drivers and barriers to patient participation in RCTs. British Journal of Cancer 108, 1402-1407, 2013, doi:10.1038/bjc.2013.113

Jenkins V, Farewell D, Farewell V, Batt L, Wagstaff J, Langridge C, Fallowfield LJ Teams Talking Trials: Results of an RCT to improve the communication of cancer teams about treatment trials. Contemporary Clinical Trials 35(1): 43-51, 2013 doi:10.1016/j.cct.2013.02.003

Ring A, Harder H, Langridge C, Ballinger RS, Fallowfield LJ Adjuvant chemotherapy in elderly women with breast cancer (AChEW): an observational study identifying MDT perceptions and barriers to decision making. Annals of Oncology 24(5): 1211-9, 2013. doi:10.1093/annonc/mds642



^ Top

Cardoso F, Harbeck N, Fallowfield L, Kyriakides S, Senkus E, on behalf of the ESMO Guidelines Working Group. Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 23 (Supplement 7): vii11-vii19, 2012, doi:10.1093/annonc/mds232

Fallowfield LJ, Francis A, Catt S, Mackenzie M, Jenkins V. Time for a low-risk DCIS trial: harnessing public and patient involvement, Lancet Oncology 13(12): 3055-64, 2012. doi:10.1016/S1470-2045(12)70503-X

Simcock R, Fallowfield LJ, Monson K, Solis-Topala I, Parlour L, Langridge C, Jenkins V, on behalf of the ARIX Steering Committee. ARIX: A randomised trial of acupuncture v oral care sessions in patients with chronic xerostomia following treatment of head and neck cancer, Annals of Oncology 24(3): 776-783, 2012. doi: 10.1093/annonc/mds515

Harder H, Parlour L, Jenkins V Randomised controlled trials of yoga interventions for women with breast cancer: a systematic literature review. Supportive Care In Cancer 20(12): 3055-64 2012. doi:10.1007/s00520-012-1611-8

Fallowfield LJ, von Moos R, Costa L, Stopeck A, Clemons M, Clarke N, Braun A, Chung K. Weighing Bone-targeted Treatment Options for Patients with Solid Tumours and Skeletal Complications from Metastatic Disease. European Oncology & Haematology, 2012;8(3):148–55.

Catt S, Chalmers A, Critchley G, Fallowfield LJ. Supportive follow-up in patients treated with radical intent for high-grade glioma. CNS Oncology, September 2012, Vol. 1, No. 1, Pages 39-48.

Cleeland CS, Body JJ, Stopek A, von Moos R, Fallowfield LJ et. al. Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of Denosumab and Zoledronic Acid. 2012, 119(4):832-838 doi:10.1002/cncr.27789

Martin M, Bell R, Bourgeois H et al. Bone-related complications and QoL in advanced breast cancer: results from a randomised phase III trial of Denosumab versus Zoledronic Acid. Clin Cancer Res, 2012 Sep 1;18(17):4841-4849. Epub 2012 Aug 14. doi:10.1158/1078-0432.CCR-11-3310

Gentry-Maharaj A, Sharma A, Burnell M, Ryan A, Amso NN, Seif MW, Turner G, Brunell C, Fletcher G, Rangar R, Fallowfield LJ, Campbell S, Jacobs I, Menon U. Acceptance of transvaginal sonography by postmenopausal women participating in the United Kingdom Collaborative Trial of Ovarian Cancer Screening. Ultrasound Obstetrics and Gynecology 2012, 41(1):73-79. doi:10.1002/uog.12262.

Vadhan-Raj S, von Moos R, Fallowfield LJ, Patrick DL, Goldwasser F, Cleeland CS, Henry DH, Novello S, Hungria V, Qian Y, Feng A, Yeh H, Chung K. Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acid. Annals of Oncology 2012, 23(12): 3045-51, doi:10.1093/annonc/mds175

Fallowfield LJ, Solis-Trapala I, Jenkins V Evaluation of an educational program to improve communication with patients about early-phase trial participation. The Oncologist, 2012;17:377-383. doi:10.1634/theoncologist.2011-0271 (see also accompanying editorial: Flamm, et al. Communicating About Phase I Trials: Objective Disclosures Are Only A First Step, The Oncologist 2012; 17:466-468)

Cardoso F, et al., 1st International consensus guidelines for advanced breast cancer (ABC 1), The Breast (2012) 21(3):242-252, doi:10.1016/j.breast.2012.03.003

Fallowfield LJ, Kilburn LS, Langridge C, Snowdon CF, Bliss JM, Coombes RC on behalf of the IES Trial Steering Committee Long-term assessment of QoL in the Intergroup Exemestane Study: 5 years post-randomisation. British Journal of Cancer (2012), 1-6. doi:10.1038/bjc.2012.43

Ford E, Catt S, Chalmers A, Fallowfield LJ. Systematic review of supportive care needs in patients with primary malignant brain tumours. Neuro-Oncology Advance Access published February 3, 2012. doi:10.1093/neuonc/nor229


^ Top

Susan L. Catt, John L. Anderson and Giles R. Critchley.  Patients’ and staff’s experiences of multidisciplinary follow-up for high-grade glioma after radical radiotherapy.  Psychology, Health & Medicine, Vol. 16, No. 3, May 2011, 357–365

Matza LS, Fallowfield LJ, Chung K, Currie BM, Van Brunt K, Patrick DL. Patient-reported outcome instruments used to assess pain and functioning in studies of bisphosphonate treatment for bone metastases. Support Care Cancer, 12 December 2011. doi:10.1007/s00520-011-1356-9

Talk summary by Fallowfield LJ. Talking to patients about clinical trial entry from Phase I to Phase III. Le Journal du Cancer de L'Institut Jules Bordet, No 20, 2011, p.18.

Cardoso F, Fallowfield LJF, Costa A, Castiglione M, Senkus E, on behalf of the ESMO Guidelines Working Group. Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 22 (Supplement 6): vi25-v130, 2011. doi:10.1093/annonc/mdr372

Letter to the British Medical Journal, "What should women do in the meantime?", Fallowfield LJF. BMJ 2011;343:d7544.

Monson K, Parlour L, Simcock R, Fallowfield LJ, Jenkins V. Group recruitment sessions enhance patient understanding in a small multi-centre phase III clinical trial. Contemp Clin Trials (2012) 33(2);286-290 doi:10.1016/j.cct.2011.11.003

R Leonard, R Ballinger, D Cameron, P Ellis, L Fallowfield, M Gosney, L Johnson, L S Kilburn, A Makris, J Mansi, M Reed, A Ring, A Robinson, P Simmonds, G Thomasand J M Bliss. Adjuvant chemotherapy in older women (ACTION) study - what did we learn from the pilot phase? British Journal of Cancer (2011) 105, 1260-1266. doi:10.1038/bjc.2011.377

Fallowfield LJ, Fleissig, A. The value of progression-free survival to patients with advanced-stage cancer. Nat. Rev. Clin. Oncol. 9,41-47 (2012); published online 18 October 2011. doi:10.1038/nrclinpnc.2011.156

Jenkins V, Harder H, Babar M, Merry S, Newbury S, Kissin M, Zammit C. A pilot study to examine the experiences and attitudes of women with breast cancer towards one versus two-step axillary surgery. The Breast, February 2012, 21 (1)72-76 doi:10.1016/j.breast.2011.08.125

Jenkins V, Trapala SI, Parlour L, Langridge CI, Fallowfield LJ. The views of patients and the general public about expensive anti-cancer drugs in the NHS: a questionnaire-based study. Journal of the Royal Society of Medicine, Short Reports (2011) doi:10.1258/shorts.2011.011050

Ring A, Reed M, Leonard R, Kunkler I, Muss H, Wildiers H, Fallowfield L, Jones A and Coleman R. The treatment of early breast cancer in women over the age of 70. British Journal of Cancer (2011) 105, 189-193

Treasure T, Fallowfield LJ, Lees B, Farewell V. Pulmonary metastasectomy in colorectal cancer: the PulMiCC trial. Thorax 1 Feb 2012 67: 185-187 doi:10.1136/thoraxjnl-2011-200015

Ballinger R, Ford E, Pennery E, Jenkins V, Ring A, Fallowfield LJ. Specialist breast care and research nurses' attitudes to adjuvant chemotherapy in older women with breast cancer. European Journal of Oncology Nursing. February 2012;16(1):78-86. E-Published 7th May 2011 ahead of print. doi:10.1016/j.ejon.2011.03.011

Fallowfield LJ, Solis-Trapala I, Jones A, Barrett J, Langridge C, Jenkins V. Discussing expensive anti-cancer drugs. British Journal of Healthcare Management 17(5): 206 - 212 (May 2011)

Ford E, Jenkins V, Fallowfield L, Stuart N, Farewell D, Farewell V. Clinicians' attitudes towards clinical trials of cancer therapy. British Journal of Cancer, (12 April 2011) doi:10.1038/bjc.2011.119

Catt S, Langridge C, Fallowfield L, Talbot DC, Jenkins V. Reasons given by patients for participating, or not, in Phase 1 cancer trials, Eur J Cancer (2011), doi:10.1016/j.ejca.2011.02.020

Burnell M, Gentry- Maharaj A, Ryan A, Apostolidou S, Habib M, Kalsi J, Skates S, Parmar M, Seif MW, Amso NN, Godfrey K, Oram D, Herod J, Williamson K, Jenkins H, Mould T, Woolas R, Murdoch J, Dobbs S, Leeson S, Cruickshank D, Campbell S, Fallowfield L, Jacobs I, Menon U Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trialsTrials 2011, 12:61 doi:10.1186/1745-6215-12-61

Jacobs I, Gentry- Maharaj A, Burnell M, Manchanda R, Singh N, Sharma A, Ryan A, Seif MW, Amso NN, Turner G, Brunell C, Fletcher G, Rangar R, Ford K, Godfrey K, Lopes A, Oram D, Herod J, Williamson K, Scott I, Jenkins H, Mould T, Woolas R, Murdoch J, Dobbs S, Leeson S, Cuickshank D, Skates SJ, Fallowfield L, Parmar M, Campbell S, Menon U. Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort Lancet Oncology 2011;12:38-48. doi:10.1016/S1470-2045(10)70268-0

Catt S, Anderson J, Chalmers A, Fallowfield LJ A UK-wide survey of follow-up practices for patients with high-grade glioma treated with radical intent.Journal of Evaluation in Clinical Pratice 2011 Feb;17(1):1-6. doi: 10.1111/j.1365-2753.2009.01292.x.

Dixon J, Renshaw L, Langridge C, Young O, McHugh M, Williams L, Murray J, Macaskill J, McCaig F, Dixon O, Fallowfield LJ. Anastrozole and letrozole: an investigation and comparison of QoL and tolerability. Breast Cancer Research and Treatment, 125(3):741-749 Feb 2011. doi:10.1007/s10549-010-1091-9

Jenkins V, Solis-Trapala I, Langridge C, Catt S, Talbot DC, Fallowfield LJ What oncologists believe they said and what patients believe they heard: an analysis of Phase 1 Trial discussions. JCO January 1, 2011 vol. 29 no. 1 61-68 doi:10.1200/JCO.2010.30.0814


^ Top

Cardoso F, Senkus-Konefka E, Fallowfield L, Costa A, Catiglione M on behalf of the ESMO Guidelines Working Group. Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 2010, 21 Suppl 5:v15-9 doi:10.1093/annonc/mdq160

Treasure T, Fiorentino F, Hunt I, Fallowfield LJ, Utley M Current concepts: pulmonary metastasectomy for colorectal cancer. The European Journal of Oncological Medicine, Vol II, Issue II June 2010, June 2010.

Simcock R, Jenkins V Acupuncture and Xerostomia. British Medical Journal, 2010;28:167-168 doi:10.1136/aim.2010.003293

Jenkins V, Farewell D, Batt L, Maughan T, Branston L, Langridge C, Parlour L, Farewell V, Fallowfield LJ The attitudes of 1066 patients with cancer towards participation in randomised clinical trials. British Journal of Cancer (2010) 103, 1801-1807, doi:10.1038/sj.bjc.6606004

Mayer M, Hunis A, Oratz R, Glennon C, Spicer P, Caplan E, Fallowfield LJ Living with metastatic breast cancer: a global patient survey. Commun Oncol 2010;7:406–412.

Fallowfield LJ, Fleissig A, Barrett J, Menon U, Jacobs I, Kilkerr J and Farewell V. Awareness of ovarian cancer risk factors, beliefs and attitudes towards screening: baseline survey of 21,715 women participating in the UK Collaborative Trial of Ovarian Cancer Screening. British Journal of Cancer 103, 454-461, doi:10.1038/sj.bjc.6605809

Treasure T, Fallowfield LJ, Lees B. Pulmonary Metastasectomy on Colorectal Cancer: The PulMiCC Trial. Journal of Thoracic Oncology, 2010:5, S203-S206. doi:10.1097/JTO.0b013e3181dca239

Fallowfield LJ, Stebbing J, Braybrooke, J, Langridge C, Jenkins V The preferences and experiences of different bisphosphonate treatments in women with breast cancer. Psycho-Oncology (2010). doi:10.1002/pon.1781

Smith AB, Fallowfield LJ, Stark DP, Velikova G, Jenkins V A Rasch and confirmatory factor analysis of the General Health Questionnaire (GHQ)-12. Health and QoL Outcomes 2010,8:45, doi:10.1186/1477-7525-8-45

Jenkins V, Anderson, J, Fallowfield LJ Communication and informed consent in phase 1 trials: a review of the literature from January 2005 to July 2009. Supportive Care In Cancer Volume 18, Number 9, 1115-1121 doi:10.1007/s00520-010-0836-7

Fallowfield LJ Communication with patients after errors J Health Serv Res Policy Vol 15, Suppl 1, January 2010. doi:10.1258/jhsrp.2009.09s107


^ Top

Stifel F, Barth J, Bensing J, Fallowfield LJ, Jost L, Razavi D, Kiss A for the participants Communication skills training in oncology: a position paper based on a consensus meeting among European experts in 2009. Annals of Oncology, doi:10.1093/annonc/mdp564

Fallowfield LJ The challenge of interacting with patients in oncology. European Journal of Cancer, Volume 45, Supplement 1, Joint ECCO 15 - 34th ESMO Multidisciplinary Congress Education Book, September 2009, pp.445-446. doi:10.1016/S0959-8049(09)70083-8 

Fallowfield LJ. The clinical importance of patient adherence to therapy. Advances in Breast Care, June 2009, Vol. 6.2, 9-11.

Jenkins V, Low R, Mitra S. Hearing sensitivity in women following chemotherapy treatment for breast cancer: results from a pilot study, The Breast (2009), doi: 10.1016/j.breast.2009.07.004

Fatima Cardoso, Philippe L. Bedard, Eric P. Winer, Olivia Pagani, Elzbieta Senkus-Konefka, Lesley J. Fallowfield, Stella Kyriakides, Alberto Costa, Tanja Cufer, Kathy S. Albain, and on behalf of the ESO-MBC Task Force International Guidelines for Management of Metastatic Breast Cancer: Combination vs Sequential Single-Agent Chemotherapy. Journal of the National Cancer Institute Advance Access published on August 5, 2009. doi:10.1093/jnci/djp235

Simcock R, Fallowfield LJF, Jenkins V Group acupuncture to relieve radiation induced xerostomia: a feasibility study. Acupuncture Medicine 2009;Ser. 27(3), 109-13.

Fallowfield LJF What is QoL?May 2009.

Fallowfield LJF, Jenkins V QoL issues during adjuvant endocrine therapy. Cancer Treatment and Research 2009; 151 353-65. doi:10.1007/978-0-387-75115-3_22

Menon U, Gentry-Maharaj A, Hallett R, Ryan A, Burnell M, Sharma A, Lewis S, Davies S, Philpott S, Lopes A. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol 2009; 10: 327-40. doi: 10.1016/S1470-2045(09)70026-9.

Ballinger RS, Fallowfield LJ QoL and patient-reported outcomes in the older breast cancer patient. Clinical Oncology (2009) 21: 140-155. doi:10.1016/j.clon.2008.11.003

Treasure T, Fallowfield LJ, Farewell V, Ferry D, Lees B, Leonard P, Macbeth F, Utley M (for the Pulmonay Metastasectomy in Colorectal Cancer (PulMiCC) trial development group). Pulmonary metastasectomy in colorectal cancer: Time for a trial. European Journal of Surgical Oncology (2009), doi: 10.1016/j.ejso.2008.12.005


^ Top

Fallowfield LJ, George D Section introduction: Introduction to the sessions on 'Debate: Extended follow-up of breast cancer patients in clinic wastes time for both patients and doctors'. Breast Cancer Research 2008, 10(Suppl 4):S6. doi: 10.1186/bcr2166

Fallowfield LJ Short communication: Psychosocial aspects of risk appraisal Breast Cancer Research 2008, 10(Suppl 4):S14. doi:10.1186/bcr2174

Cuzick J, Sestak I, Cella D, Fallowfield LJ, on behalf of the ATAC Triallists' Group Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial. Lancet Oncology 9(12); 1143 - 1148

Ballinger R, Fortes Mayer K, Lawrence G, Fallowfield LJ Patients' decision-making in a UK specialist centre with high mastectomy rates. The Breast (2008). doi:10.1016/j.breast.2008.08.001

Jenkins V, Amroisine L, Atkins L, Cuzick J, Howell A, Fallowfield LJ Effects of Anastrozole on cognitive performance in postmeopausal women: a randomised, double-blind chemoprevention trial (IBIS II). Lancet Oncology 2008, 9: 953-961. doi: 10.1016/S1470-2045(08)70207-9.

Catt A, Chalmers A, Fallowfield LJ Psychosocial and supportive-care needs in high-grade glioma. Lancet Oncology 2008; 9:884-91. doi:10.1016/S1470-2045(08)70230-4

Smith AB, Rush R, Fallowfield LJ, Velikova G, Sharpe M Rasch fit statistics and sample size considerations for polytomous data. BMC Medical Research Methodology 2008, 8:33. doi:10.1186/1471-2288-8-33

Fallowfield LJ Treatment decision-making in breast cancer: the patient-doctor relationship. Breast Cancer Res Treat, published online 11 June 2008. doi:10.1007/s10549-008-0077-3

Lansdown M, Martin L, Fallowfield LJ Patient-physician interactions during early breast cancer treatment: results from an international online survey. Current Medical Research and Opinions, Vol.24, No.7, 2008. doi:10.1185/03007990802135042

Fallowfield LJ The importance of communication in treating women with breast cancer. Oncology, Vol. 22, No.6, May 2008.

Fallowfield LJ, Jenkins V, Coleman R Which bisphosphonates do oncologists prescribe for women with metastatic breast cancer and why? Results of a UK survey. The Breast (2008), doi:10.1016/j.breast.2008.02.009

Fallowfield LJ There's many a slip twixt cup and lip: adherence issues in cancer therapy. Nature Clinical Practice Oncology, published online 15 January 2008, doi: 10.1038/ncponc1043


^ Top

Fallowfield LJ Section introduction: Psychosocial controversies in breast cancer. Breast Cancer Research 2007, 9(Suppl 2):S2, doi:10.1186/bcr1800.

Fallowfield LJ Short communication: Why patient recorded outcomes should be mandatory in and outside clinical trials to guide management of patients with metastatic breast cancer. Breast Cancer Research 2007, 9(Suppl 2):S7, doi: 10.1186/bcr1805.

The Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trialists' Group Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. Lancet Oncology 2008; 9: 45–53 e-published 15 December 2007. doi:10.1016/S1470-2045(07)70385-6

Cella D, Fallowfield LJ Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy. Breast Cancer Research and Treatment (2008)107:167-180 e-published 18 September 2007, doi:10.1007/s10549-007-9548-1

Fallowfield LJ, Atkins L Fallowfield's Sexual Activity Questionnaire in women with, without and at risk of cancer. Menopause International (2007) 13:7-14 doi:10.1258/175404507781605578

Fallowfield LJ QoL issues in relation to the aromatase inhibitor. Journal of Steroid Biochemistry & Molecular Biology 106 (2007) 168-172, doi:10.1016/j.jsbmb.2007.05.003

Mansel R, Locker G, Fallowfield LJ, Benedict A, Jones D on behalf of the ATAC Trialists' Group. Cost-effectiveness analysis of anastrozole vs tamoxifen in adjuvant therapy for early stage breast cancer in the United Kingdom: the 5-year completed treatment analysis of the ATAC ('Arimidex', Tamoxifen alone or in combination) trial. British Journal of Cancer 2007; 97, 152-161, doi:10.1038/sj.bjc.6603804

Newton Bishop J, Taylor T, Potts H, Elliott F, Pinney E, Barrett J, Bishop D, Fallowfield LJ. Sun-protective behaviours in families at increased risk of melanoma. Journal of Investigative Dermatology 2007; 127 1343-1350, doi:10.1038/sj.jid.5700764

Jenkins V, Atkins L, Fallowfield LJ. Does endocrine therapy for the treatment and prevention of breast cancer affect memory and cognition? European Journal of Cancer 2007, doi:10.1016/j.ejca.2007.03.023

Stead M, Fallowfield LJ, Selby P, Brown J Psychosexual function and impact of gynaecological cancer. Best Practice and Research Clinical Obstetrics and Gynaecology 2007; 21(2): 309-320, doi:10.1016/j.bpobgyn.2006.11.008

MBC Task Force Metastatic breast cancer guidelines. The Breast 2007; 16; 9-10, doi:10.1016/j.breast.2006.11.002 (pdf only).

Coombes RC, Kilburn LS, Snowdon CF, Paridaens R, Coleman RE, Jones SE, Jassem J, Van de Velde CJH, Delozier T, Alvarez I, Del Mastro L, Ortmann O, Diedrich K, Coates AS, Bajetta E, Holmberg SB, Dodwell D, Mickiewicz E, Andersen J, Lonning PE, Cocconi G, Forbes J, Castiglione M, Stuart N, Stewart A, Fallowfield LJ, Bertelli G, Hall E, Bogle RG, Carpentieri M, Colajori E, Subar M, Ireland E, Bliss JM and on behalf of the Intergroup Exemestane Study Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial. Lancet 2007; 369: 559-70, doi:10.1016/S0140-6736(07)60200-1


^ Top

Cox A, Fallowfield LJ.  After going through chemotherapy I can't see another needle.  European Journal of Oncology Nursing (2007) 11, 43–48 epublished 7 Jul 2006. doi:10.1016/j.ejon.2006.04.035

Fleissig A, Jenkins V, Catt S, Fallowfield LJ Multidisciplinary teams in cancer care: are they effective in the UK? Lancet Oncology 2006; 7(11):935-43, doi:10.1016/S1470-2045(06)70940-8

Shilling V, Jenkins V Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer. European Journal of Oncology Nursing 2006; 11: 6-15, doi:10.1016/j.ejon.2006.02.005

Cella D, Fallowfield LJ, Barker P, Cuzick J, Locker G, Howell A QoL of postmenopausal women in the ATAC ('Arimidex', Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for early breast cancer. Breast Cancer Research and Treatment 2006; 100(3):273-284, doi:10.1007/s10549-006-9260-6

The ATAC Trialists' Group Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial. The Lancet Oncology 2006; 7(8):633-43, doi:10.1016/S1470-2045(06)70767-7

Sharma A, Beveridge H, Fallowfield LJ, Jacobs I, Menon U Postmenopausal women undergoing transvaginal ultrasound screening prefer not to have chaperones. An International Journal of Obstetrics and Gynaecology 2006; 113:954-57, doi:10.1111/j.1471-0528.2006.01009.x

McGurk R, Fallowfield LJ, Winters Z Information provision for patients by breast cancer teams about the side-effects of hormone treatments. European Journal of Cancer 2006; 42(12):1760-7, doi:10.1016/j.ejca.2006.03.014

Cox AC, Fallowfield LJ, Jenkins V Communication and informed consent in phase 1 trials: a review of the literature. Support Care Cancer 2006; 14(4):303-9, doi:10.1007/s00520-005-0916-2

Mansel RE, Fallowfield LJ, Kissin M, Goyal A, Newcombe RG, Dixon JM, Yiangou C, Horgan K, Bundred N, Monypenny I, England D, Sibbering M, Abdullah TI, Barr L, Chetty U, Sinnett DH, Fleissig A, Clarke D, Ell PJ Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. Journal of the National Cancer Institute 2006; 98(9)599-609, doi:10.1093/jnci/djj158

Atkins L, Fallowfield LJ Intentional and non-intentional non-adherence to medication amongst breast cancer patients. European Journal of Cancer 2006; 42(14):2271-6, doi:10.1016/j.ejca.2006.03.004

Goldstein LH, Atkins L, Landau S, Brown R, Leigh PN Predictors of psychological distress in carers of people with amyotrophic lateral sclerosis: a longitudinal study. Psychological Medicine 2006; 36:1-11, doi:10.1017/S0033291706007124

Jenkins V, Shilling V, Deutsch G, Bloomfield D, Morris R, Allan S, Bishop H, Hodson N, Mitra S, Sadler G, Shah E, Stein R, Whitehead S, Winstanley J A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. British Journal of Cancer 2006; 94(6):828-34, doi:10.1038/sj.bjc.6603029

Fallowfield LJ, Bliss JM, Porter LS, Price MH, Snowdon CF, Jones SE, Coombes RC, Hall E QoL in the intergroup exemestane study: a randomised trial of exemestane versus continued tamoxifen after 2 to 3 years of tamoxifen in postmenopausal women with primary breast cancer. Journal of Clinical Oncology 2006; 24(6):910-7, doi:10.1200/JCO.2005.03.3654

Catt S, Fallowfield LJ, Langridge C What non-prescription treatments do UK women with breast cancer use? European Journal of Cancer Care 2006; 15(3):279-85, doi:10.1111/j.1365-2354.2006.00652.x

Cox A, Jenkins V, Catt S, Langridge C, Fallowfield LJ Information needs and experiences: an audit of UK cancer patients. European Journal of Oncology Nursing 2006; 10(4):263-72, doi:10.1016/j.ejon.2005.10.007

Jenkins V, Beveridge H, Low R, Mitra S Atypical hearing loss in women with breast cancer receiving adjuvant treatment. The Breast 2006; 15(3):448-51, doi:10.1016/j.breast.2005.06.005

Fallowfield LJ, Atkins L, Catt S, Cox A, Coxon C, Langridge C, Morris R, Price M Patients' preference for administration of endocrine treatments by injection or tablets: results from a study of women with breast cancer. Annals of Oncology 2006; 17(2):205-10, doi:10.1093/annonc/mdj044


^ Top

Duric VM, Fallowfield LJ, Saunders C, Houghton J, Coates AS, Stockler MR Patients’ preferences for adjuvant endocrine therapy in early breast cancer: what makes it worthwhile? British Journal of Cancer 2005; 93:1319–1323, doi:10.1038/sj.bjc.6602874

Shilling V, Jenkins V, Solis-Trapala I The (mis)classification of chemo-fog: methodological inconsistencies in the investigation of cognitive impairment after chemotherapy. Breast Cancer Research and Treatment 2005, doi:10.1007/s10549-005-9055-1

Catt S, Fallowfield LJ, Jenkins V, Langridge C, Cox A The informational roles and psychological health of members of 10 oncology multidisciplinary teams in the UK. British Journal of Cancer 2005; 93(10)1092-7, doi:10.1038/sj.bjc.6602816

Fleissig A, Fallowfield LJ, Langridge CI, Johnson L, Newcombe RG, Dixon JM, Kissin M, Mansel RE. Post-operative arm morbidity and QoL. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Research and Treatment 2005; Sep 15, 1-15, doi:10.1007/s10549-005-9025-7

Fallowfield LJ Acceptance of adjuvant therapy and QoL issues. The Breast 2005; 14(6):612-616, doi:10.1016/j.breast.2005.08.012

Catt S, Blanchard M, Addington-Hall J, Zis M, Blizard R, King M Older adults' attitudes to death, palliative treatment and hospice care. Palliative Medicine 2005; 19(5):402-410, doi:10.1191/0269216305pm1037oa

Catt S, Blanchard M, Addington-Hall J, Zis M, Blizard R, King M The development of a questionnaire to assess the attitudes of older people to end-of-life issues (AEOLI). Palliative Medicine 2005; 19:397-401, doi:10.1191/0269216305pm1036oa

Jenkins V, Fallowfield LJ, Edginton T, Payne H, Hamilton E Preferences of healthy men for two different endocrine treatment options offered for locally advanced prostate cancer. Current Medical Research and Opinion 2005; 21(9):1329-1335, doi:10.1185/030079905X59058

Fallowfield LJ Learning how to communicate in cancer settings. Supportive Care in Cancer 2005; 13(6):349-50, doi:10.1007/s00520-004-0765-4

Jenkins V, Bloomfield DJ, Shilling VM, Edginton TL Does neoadjuvant hormone therapy for early prostate cancer affect cognition? Results from a pilot study. British Journal of Urology 2005; 96:48-53, doi:10.1111/j.1464-410X.2005.05565.x

Fallowfield LJ, Harper P Health-related QoL in patients undergoing drug therapy for advanced non-small-cell lung cancer. Lung Cancer 2005; 48:365-377, doi:10.1016/j.lungcan.2004.11.018

Roy R, Symonds RP, Kumar DM, Ibrahim K, Mitchell A, Fallowfield LJ The use of denial in an ethnically diverse British cancer population: a cross-sectional study. British Journal of Cancer 2005; 92(8):1393-7, doi:10.1038/sj.bjc.6602523

Shilling V, Jenkins V, Morris R, Deutsch G, Bloomfield D The effects of adjuvant chemotherapy on cognition in women with breast cancer - preliminary results of an observational longitudinal study. The Breast 2005; 14:142-150, doi:10.1016/j.breast.2004.10.004

Jenkins V, Fallowfield LJ, Cox A The preferences of 600 patients for different descriptions of randomisation. British Journal of Cancer 2005; 92(5):807-10

Jenkins V, Fallowfield LJ, Solis-Trapala I, Langridge C, Farewell V Discussing randomised clinical trials of cancer therapy: evaluation of a Cancer Research UK training programme. British Medical Journal 2005; 3330:400, doi:10.1136/bmj.38366.562685.8F


^ Top

Fallowfield LJ, Cella D, Cuzick J, Francis S, Locker G, Howell A. QoL of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial. Journal of Clinical Oncology 2004; 22(21):4261-71, doi:10.1200/JCO.2004.08.029

Fallowfield LJ Evolution of breast cancer treatments: current options and quality-of-life considerations. European Journal of Oncology Nursing 2004; 8S:S75-S82, doi:10.1016/j.ejon.2004.09.005

Goyal A, Newcombe RG, Mansel RE, Chetty U, Ell P, Fallowfield LJ, Kissin M, Sibbering M Sentinel lymph node biopsy in patients with multifocal breast cancer. European Journal of Surgical Oncology 2004; 30:475-479, doi:10.1016/j.ejso.2004.02.009

Goyal A, Horgan K, Kissin M, Yiangou C, Sibbering M, Lansdown M, Newcombe RG, Mansel RE, Chetty U, Ell P, Fallowfield LJ Sentinel lymph node biopsy in male breast cancer patients. European Journal of Surgical Oncology 2004; 30:480-483, doi:10.1016/j.ejso.2004.02.006

Fallowfield LJ, McGurk R, Dixon M Same gain, less pain: potential patient preferences for adjuvant treatment in premenopausal women with early breast cancer. European Journal of Cancer 2004; 40:2403-2410, doi:10.1016/j.ejca.2004.07.013

Jones M, Schenkel B, Just J, Fallowfield LJ Epoetin Alfa improves QoL in patients with cancer: results of a metaanalysis. Cancer 2004; 101(8):1720-1732, doi:10.1002/cncr.20569

Thomas JM, Newton-Bishop J, A'Hern R, Coombes G, Timmons M, Evans J, Cook M, Theaker J, Fallowfield LJ Excision margins in high-risk malignant melanoma. New England Journal of Medicine 2004; 350(8):757-66

Sydes MR, Stephens RJ, Moore AR, Aird EG, Bidmead AM, Fallowfield LJ, et al Implementing the UK Medical Research Council (MRC) RT01 trial (ISRCTN 47772397): methods and practicalities of a randomised controlled trial of conformal radiotherapy in men with localised prostate cancer. Radiotherapy & Oncology 2004; 72(2):199-211, doi:10.1016/j.radonc.2004.04.007

Macleod U, Ross S, Fallowfield LJ, Watt GCM Anxiety and support in breast cancer: is this different for affluent and deprived women? A questionnaire study. British Journal of Cancer 2004; 91(5):879-83, doi:10.1038/sj.bjc.6602072

Fallowfield LJ, Fleissig A Communication with patients in the context of medical error. Health Care Risk Special Report March 2004.

Coombes RC, Hall E, Gibson LJ, Paridaens R, Jassem J, Delozier T, Jones SE, Alvarez I, Bertelli G, Ortmann O, Coates AS, Bajetta E, Dodwell D, Coleman RE, Fallowfield LJ, Mickiewicz E, Andersen J, Lonning PE, Cocconi G, Stewart A, Stuart N, Snowdon CF, Carpentieri M, Massimi G, Bliss J (for the Intergroup Exemestane Study) A randomized trial of Exemestane after two to three years of Tamoxifen therapy in postmenopausal women with primary breast cancer. New England Journal of Medicine 2004; 350(11):1081-1092

Fallowfield LJ, Jenkins V Communicating sad, bad, and difficult news in medicine. Lancet 2004; 363:312-19, doi:10.1016/S0140-6736(03)15392-5

Jenkins V, Shilling V, Fallowfield LJ, Howell A, Hutton S Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study. Psycho-Oncology 2004; 13:61-66, doi:10.1002/pon.709


^ Top

Shilling V, Jenkins V, Fallowfield LJ, Howell A The effects of hormone therapy on cognition in breast cancer. Journal of Steroid Biochemistry and Molecular Biology 2003; 86:405-412, doi:10.1016/j.jsbmb.2003.07.001

Porteous M, Dunckley M, Appleton S, Catt S, Dunlop M, Campbell H, Cull A Is it acceptable to approach colorectal cancer patients at diagnosis to discuss genetic testing? A pilot study. British Journal of Cancer 2003; 89(8):1400-2, doi:10.1038/sj.bjc.6601332

Bebbington Hatcher M, Fallowfield LJ A qualitative study looking at the psychosocial implications of bilateral prophylactic mastectomy. The Breast 2003; 12:1-9, doi:10.1016/S0960-9776(02)00135-2

Fallowfield LJ, Jenkins V, Farewell V, Solis-Trapala I Enduring impact of communication skills training: results of a 12-month follow up. British Journal of Cancer 2003; 89:1445-1449, doi:10.1038/sj.bjc.6601309

Shilling V, Jenkins V, Fallowfield LJ Factors affecting patient and clinician satisfaction with the clinical consultation: Can communication skills training for clinicians improve satisfaction? Psycho-Oncology 2003; 12(6):599-611, doi:10.1002/pon.731

Chapman K, Abraham C, Jenkins V, Fallowfield LJ Lay understanding of terms used in cancer consultations. Psycho-Oncology 2003; 12(6):557-566, doi:10.1002/pon.673

Fallowfield LJ Quality-of-life advantage following epoetin alfa treatment. Anemia in Oncology 2003; 1(2):3-6

Stead ML, Brown JM, Fallowfield LJ, Selby P Lack of communication between healthcare professionals and women with ovarian cancer about sexual issues. British Journal of Cancer 2003; 88:666-671, doi:10.1038/sj.bjc.6600799


^ Top

Fallowfield LJ Talking about difficult things in cancer: Do we achieve what patients need? Drugs of Today 2002; 38(Suppl. A):79-87

Fallowfield LJ, Gagnon D, Zagari M, Cella D, Bresnahan B, Littlewood TJ, McNulty P, Gorzegno G, Freund M for the Epoetin Alfa Group Multivariate regression analyses from a randomised, double-blind, placebo-controlled study confirm QoL benefit of epoetin alfa in patients receiving non-platinum chemotherapy. British Journal of Cancer 2002; 87(11):1341-1353, doi:10.1038/sj.bjc.6600657

Fallowfield LJ, Jenkins V Acronymic trials: the good, the bad and the coercive. Lancet 2002; 360:1622, doi:10.1016/S0140-6736(02)11653-9

Fallowfield LJ QoL: a new perspective for cancer patients. Nature Reviews Cancer 2002; 2:873-879, doi:10.1038/nrc930

Jenkins V, Leach L, Fallowfield LJ, Nicholls K, Newsham A Describing randomisation: Patients' and the public's preferences compared with clinicians' practices. British Journal of Cancer 2002; 87:854-858, doi:10.1038/sj.bjc.6600527

Fallowfield LJ, Jenkins V, Beveridge H Truth may hurt but deceit hurts more: communication in palliative care. Palliative Medicine 2002; 16:297-303, doi:10.1191/0269216302pm575oa

Fallowfield LJ, Jenkins V, Farewell V, Saul J, Duffy A, Eves, R Efficacy of a Cancer Research UK communications skills training model for oncologists: a randomised controlled trial. Lancet 2002; 359(9307):650-656, doi:10.1016/S0140-6736(02)07810-8

Jenkins V, Fallowfield LJ Can communication skills training alter physicians' beliefs and behavior in clinics? Journal of Clinical Oncology 2002; 20(3):765-769

Poole K, Fallowfield LJ The psychological impact of post-operative arm morbidity following axillary surgery for breast cancer: a critical review. The Breast 2002; 11:81-87, doi:10.1054/brst.2001.0369

Coster S, Fallowfield LJ The impact of endocrine therapy on patients with breast cancer: a review of the literature. The Breast 2002; 11:1-12, doi:10.1054/brst.2001.0397

Shilling V, Rabbitt PMA, Chetwynd A Individual inconsistency across measures of inhibition: an investigation of the construct validity of inhibition in older adults. Neuropsychologia 2002; 40(6):605-620, doi:10.1016/S0028-3932(01)00157-9


^ Top

Rabbitt PMA, Lowe C, Shilling V Frontal tests and models for cognitive ageing. European Journal of Cognitive Psychology 2001; 13(1/2):5-28

Shilling V, Jenkins V, Fallowfield LJ, Howell A The effects of oestrogens and anti-oestrogens on cognition. The Breast 2001; 10:484-491, doi:10.1054/brst.2001.0311

Fallowfield LJ Participation of patients in decisions about treatment for cancer: desire for information is not the same as a desire to participate in decision making [editorial; comment]. British Medical Journal 2001; 323:1144, doi:10.1136/bmj.323.7322.1144

Fallowfield LJ, Goodman NW An unmerciful end [letter; comment]. British Medical Journal 2001; 323:1131. doi:10.1136/bmj.323.7321.1131

Coster S, Poole K, Fallowfield LJ The validation of a QoL scale to assess the impact of arm morbidity in breast cancer patients post-operatively. Breast Cancer Research and Treatment; 2001 68:273-282

Stead M, Fallowfield LJ, Brown J, Selby P Communication about sexual problems and sexual concerns in ovarian cancer: qualitative study. British Medical Journal 2001; 323:836-837. doi:10.1136/bmj.323.7317.836

Fallowfield LJ, Saul J, Gilligan B Teaching senior nurses how to teach communication skills in oncology. Cancer Nursing 2001; 24(3):185-191

Fellowes D, Fallowfield LJ, Saunders CM, Houghton J Tolerability of hormone therapies for breast cancer; how informative are documented symptom profiles in medical notes for 'well-tolerated' treatments? Breast Cancer Research and Treatment 2001; 66(1):73-81

Jenkins V, Fallowfield LJ, Poole K Are members of multidisciplinary teams in breast cancer aware of each other's informational roles? Quality in Health Care 2001; 10(2):70-75, doi:10.1136/qhc.10.2.70

Fallowfield LJ, Fleissig A, Edwards R, West A, Powles TJ, Howell A, Cuzick J Tamoxifen for the prevention of breast cancer: psychosocial impact on women participating in two randomised controlled trials. Journal of Clinical Oncology 2001; 19(7):1885-1892.

Fallowfield LJ, Ratcliffe D, Jenkins V, Saul J Psychiatric morbidity and its recognition by doctors in patients with cancer. British Journal of Cancer 2001; 84(8):1011-1015, doi:10.1054/bjoc.2001.1724

Fleissig A, Jenkins V, Fallowfield LJ Results of an intervention study to improve communication about randomised clinical trials of cancer therapy. European Journal of Cancer 2001; 37:322-331, doi:10.1016/S0959-8049(00)00415-9

Hatcher BM, Fallowfield LJ, A'Hern R The psychosocial impact of bilateral prophylactic mastectomy: prospective study using questionnaires and semi-structured interviews. British Medical Journal 2001; 322:76-79. doi:10.1136/bmj.322.7278.76

Jenkins V, Fallowfield LJ, Saul J Information needs of patients with cancer: results from a large study in UK cancer centres. British Journal of Cancer 2001; 84(1):48-51, doi:10.1054/bjoc.2000.1573

^ Top

Book Chapters

Fallowfield LJ, Jenkins V Psychosocial issues in breast cancer in Dixon MJ (ed.) Companion to Specialist Practice volume in Breast Surgery Fourth Edition Elseview, 2008 Chapter 16, 245-257.

Fallowfield LJ, Jenkins V Current Concepts of Communication Skills Training in Oncology. In Stiefel F (Ed) Communication in Cancer Care. Springer-Verlag Berlin Heidelberg 2006: 105-112

Fallowfield LJ, Jenkins V Psychosocial Issues in Breast Cancer. In Dixon JM, Breast Surgery: A Comparison to Specialist Surgical Practice. 3rd Edition Elsevier Saunders 2006: 235-249

Fallowfield LJ Psychosocial Aspects. In Baum M, Henderson C (Eds) Classic Papers in Breast Disease. ISIS Medical Media Ltd 2004: 372-380

Fallowfield LJ Communication with the patient and family in palliative medicine. In Oxford Textbook of Palliative Medicine. Oxford: Oxford University Press 2003: 100-107

Fallowfield LJ, Jenkins V Communication. In Souhami RL, Tannock I, Hohenberger P, Horiot J-C. (Eds) Oxford Textbook of Oncology (2nd edition). Oxford: Oxford University Press 2001: 1049-1059

Roter D, Fallowfield LJ Principles of training medical staff in psychosocial and communication skills. In Holland JC. (Ed) Psycho-Oncology. New York, Oxford: Oxford University Press 1998: 1074-1082

Fallowfield LJ Psychological aspects of surgical management. In Taylor I, Cooke TG, Guillou PJ. (Eds) Essential General Surgical Oncology. London: Churchill Livingston 1996: 421-429

Fallowfield LJ Psychological implications of tamoxifen treatment in women at high risk to breast cancer. In Maltoni C, Soffritti M, Davies W. (Eds) Proceedings of 'The Scientific Basis of Cancer Chemoprevention'. Berlin: Elselvier Science 1996

Fallowfield LJ Breast Cancer. In Baum A, McManus C, Newman S, Wienman J, West R. (Eds) Cambridge Handbook of Psychology, Health and Medicine. Cambridge: Cambridge University Press 1997: 385-390

^ Top